MetaADEDB 2.0 @ LMMD
methenolone acetate
(PGAUJQOPTMSERF-QWQRBHLCSA-N)
Structure
SMILES
CC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)C(=CC(=O)C2)C
Molecular Formula:
C22H32O3
Molecular Weight:
344.488
Log P:
4.6960
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
43.37
CAS Number(s):
434-05-9
Synonym(s)
1.
methenolone acetate
2.
Primobolan
3.
Primobolan S
4.
metenolone acetate
5.
methenolone acetate, (17beta)-isomer
External Link(s)
MeSHC033244
PubChem Compound252372
ChEBI31828
CHEMBLCHEMBL2106880
KEGGdr:D01375
ZINC4216893
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2AcidosisOFFSIDES
3AdenocarcinomaOFFSIDES
4Alanine Aminotransferase IncreasedOFFSIDES
5AngiodysplasiaOFFSIDES
6AnorexiaOFFSIDES
7AscitesOFFSIDES
8AspergillosisOFFSIDES
9Band neutrophil percentage decreasedOFFSIDES
10Blood chloride decreasedOFFSIDES
11Blood creatinine increasedOFFSIDES
12Blood glucose decreasedOFFSIDES
13Blood lactate dehydrogenase decreasedOFFSIDES
14Blood lactate dehydrogenase increasedOFFSIDES
15Blood potassium decreasedOFFSIDES
16Blood potassium increasedOFFSIDES
17Blood sodiumOFFSIDES
18Blood urea increasedOFFSIDES
19Blood uric acidOFFSIDES
20Blood urine presentOFFSIDES
21Brain natriuretic peptide increasedOFFSIDES
22BronchiectasisOFFSIDES
23Bronchoalveolar LavageOFFSIDES
24Cerebellar infarctionOFFSIDES
25Color blindnessOFFSIDES
26Cord blood transplant therapyOFFSIDES
27Creatinine renal clearance decreasedOFFSIDES
28Depressed Level of ConsciousnessOFFSIDES
29Disseminated Intravascular CoagulationOFFSIDES
30DrowsinessOFFSIDES
31DuodenitisOFFSIDES
32EczemaOFFSIDES
33Epidermal necrosisOFFSIDES
34Erythema MultiformeOFFSIDES
35Gastric ulcerOFFSIDES
36Gastrointestinal infectionOFFSIDES
37Gastrointestinal perforationOFFSIDES
38GranulomaOFFSIDES
39HiccoughOFFSIDES
40Intestinal PerforationOFFSIDES
41Kidney FailureOFFSIDES
42Left Ventricular HypertrophyOFFSIDES
43Lymphocyte count decreasedOFFSIDES
44Malignant neoplasm progressionOFFSIDES
45NasopharyngitisOFFSIDES
46Neutrophil count decreasedOFFSIDES
47OliguriaOFFSIDES
48Oropharyngeal discomfortOFFSIDES
49PCO2 decreasedOFFSIDES
50Pericardial effusionOFFSIDES
51PleurisyOFFSIDES
52PolyuriaOFFSIDES
53Pulmonary HypertensionOFFSIDES
54Pulmonary congestionOFFSIDES
55Rectal tenesmusOFFSIDES
56Septic ShockOFFSIDES
57Stevens-Johnson SyndromeOFFSIDES
58Upper respiratory tract inflammationOFFSIDES
59Visual acuity reduced transientlyOFFSIDES
60Weight GainOFFSIDES
61Wrong technique in drug usage processOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.